References to "we," "us," "company" or "our company" are to Mason Industrial
Technology, Inc. The following discussion and analysis of the Company's
financial condition and results of operations should be read in conjunction with
the unaudited condensed financial statements and the notes thereto contained
elsewhere in this report. Certain information contained in the discussion and
analysis set forth below includes forward-looking statements that involve risks
and uncertainties.

Cautionary Note Regarding Forward-Looking Statements



This Quarterly Report on Form 10-Q includes forward-looking statements within
the meaning of Section 27A of the Securities Act of 1933, as amended (the
"Securities Act"), and Section 21E of the Securities Exchange Act of 1934, as
amended (the "Exchange Act"). We have based these forward- looking statements on
our current expectations and projections about future events. These
forward-looking statements are subject to known and unknown risks, uncertainties
and assumptions about us that may cause our actual results, levels of activity,
performance or achievements to be materially different from any future results,
levels of activity, performance or achievements expressed or implied by such
forward-looking statements. In some cases, you can identify forward-looking
statements by terminology such as "may," "should," "could," "would," "expect,"
"plan," "anticipate," "believe," "estimate," "continue," or the negative of such
terms or other similar expressions. Factors that might cause or contribute to
such a discrepancy include, but are not limited to, those described in our other
U.S. Securities and Exchange Commission ("SEC") filings.

Overview



We are a blank check company incorporated as a Delaware corporation and formed
for the purpose of effecting a merger, capital stock exchange, asset
acquisition, stock purchase, reorganization or similar business combination with
one or more businesses, which we refer to throughout this Annual Report as our
initial business combination. We consummated our initial public offering on
February 2, 2021.

We currently intend to concentrate our efforts in identifying businesses in the
industrial technology, advanced materials or specialty chemicals industries
(collectively, "Advanced Industrials"). A common theme across these sectors is
the application of technology to make industrial processes more profitable,
faster, more sustainable, less capital-intensive and less complex. Specifically,
we intend to identify businesses that apply innovative technology to
engineering, production, assembly and manufacturing. These innovations include a
wide range of automation, analytics and productivity tools, as well as control
systems, high precision technologies, sustainability technologies, high
performance computing and robotics. These technologies enable companies to
confront numerous challenges inherent in their daily operations, such as rising
wage rates, globalization, increased regulation, higher quality standards,
heightened focus on sustainability and tighter timelines. We are also interested
in companies that participate in market segments that are adjacent to Advanced
Industrials. We believe that there are many potential targets within Advanced
Industrials that could become attractive public companies. These potential
targets exhibit a broad range of business models and financial characteristics,
with enterprise values ranging between $1 billion and $3 billion. They span a
wide continuum that includes both high growth emerging companies and mature
businesses with established growth profiles, recurring revenues and strong cash
flows. They are generally characterized by strong intellectual property,
differentiated product offerings, compelling customer value propositions and
corporate cultures that are data-driven and innovative.

We are not, however, required to complete our initial business combination with
an Advanced Industrials business and, as a result, we may pursue a business
combination outside of this industry. We are seeking to acquire a mature
businesses that we believe are fundamentally sound, yet which could benefit from
additional financial, operational, strategic or managerial resources to achieve
maximum value potential. We are also targeting earlier stage, yet established,
companies that exhibit the potential to disrupt the market segments in which
they participate through innovation and which offer the potential of sustained
high levels of revenue growth.

Our sponsor is affiliated with and controlled by Mason Capital, a registered
investment adviser under the Investment Advisers Act of 1940, as amended, which
was established in 2000 and had over $1.4 billion of assets under management as
of September 30, 2022.

Results of Operations

We have neither engaged in any operations nor generated any revenues to date.
All activity from our inception through the date of our IPO, February 2, 2021,
was in preparation for our IPO. Since our IPO, our activity has been limited to
the evaluation of Business Combination candidates. We do not expect to generate
any operating revenues until the closing and completion of our Business
Combination. We expect to generate non-operating income in the form of interest
income on marketable securities held after the IPO. We incur increased expenses
as a result of being a public company (for legal, financial reporting,
accounting and auditing compliance), as well as for due diligence expenses.

Comparison of the three months ended September 30, 2022 versus September 30, 2021



For the three months ended September 30, 2022, we had a net income of $4,194,536
which was primarily driven by a $2,548,000 gain from changes in fair value of
derivative liabilities, $2,260,666 of interest income on marketable securities
held in the Trust Account, and a $151,906 gain from change in fair value of the
derivative FPA. This was offset by general and administrative expenses of
$251,802, $464,234 of income tax expense, and $50,000 of franchise tax expense.

                                       18

--------------------------------------------------------------------------------

Table of Contents

For the three months ended September 30, 2021, we had a net income of $4,218,920, which was primarily driven by a $4,674,534 gain from changes in fair value of derivative liabilities, and $7,682 interest income on marketable securities held in the Trust Account. This was offset by general and administrative expenses of $255,261, $50,000 of franchise tax expense, and $158,035 loss from changes in fair value of the derivative FPA.

Comparison of the nine months ended September 30, 2022 versus September 30, 2021



For the nine months ended September 30, 2022, we had a net income of $16,902,177
which was primarily driven by a $15,797,600 gain from changes in fair value of
derivative liabilities, and $3,011,653 of interest income on marketable
securities held in the Trust Account. This was offset by general and
administrative expenses of $1,056,207, $568,045 of income tax expense, $150,136
of franchise tax expense, and $132,688 loss from changes in fair value of the
derivative FPA.

For the nine months ended September 30, 2021, we had net income of $16,649,091,
which was primarily driven by a $18,374,401 gain from changes in fair value of
derivative warrant liabilities, a $462,191 gain from changes in fair value of
the derivative FPA, and $20,040 of interest income on marketable securities held
in the Trust Account. This was partially offset by $667,878 in general and
administrative expense, $218,310 of franchise tax expense, and $1,321,353 of
issuance costs attributed to the Warrants.

As described in Note 2, Summary of Significant Accounting Policies, in "Part 1.
Financial Information - Item 1. Financial Statements," we account for (i) the
Warrants issued in connection with our IPO and Private Placement and (ii) the
forward purchase agreement as derivative instruments which were initially
recorded at their fair value. These derivative instruments are subject to
remeasurement at each balance sheet date until exercised, and any change in fair
value is recognized in our statements of operations.

Liquidity and Capital Resources



As of September 30, 2022, we had cash of $352,615 held outside the Trust
Account. We intend to use the funds held outside the Trust Account primarily to
identify and evaluate target businesses, perform business due diligence on
prospective target businesses, travel to and from the offices, plants or similar
locations of prospective target businesses or their representatives or owners,
review corporate documents and material agreements of prospective target
businesses, and structure, negotiate and complete a Business Combination.

As of September 30, 2022, we had cash and marketable securities in the Trust
Account of $502,593,553. We intend to use substantially all of the funds held in
the Trust Account, including any amounts representing interest earned on the
Trust Account (less deferred underwriting commissions) to complete our initial
Business Combination. To the extent that our capital stock or debt is used, in
whole or in part, as consideration to complete our initial Business Combination,
the remaining proceeds held in the Trust Account will be used as working capital
to finance the operations of the target business or businesses, make other
acquisitions and pursue our growth strategies.

Material cash requirements

As of September 30, 2022, we had a $300,000 convertible note outstanding. See Note 6, Related Party Transactions.



The underwriters are entitled to deferred fee of 3.5% of the gross proceeds of
the Public Offering, or $17,500,000. The deferred fee will become payable to the
underwriters from the amounts held in the trust account solely in the event that
we complete our initial business combination.

Sources of cash



Prior to the completion of the IPO, our liquidity needs were satisfied through
receipt of $25,000 from the sale of Founder Shares to Mason Industrial Sponsor
LLC, or the "Sponsor".

On February 2, 2021, we consummated the IPO of 50,000,000 Units at a price of
$10.00 per Unit generating net proceeds of $472,096,741. Transaction costs were
$27,903,259, including $10,000,000 of underwriting fees, $17,500,000 of deferred
underwriting fees and $403,259 of other offering costs in connection with the
IPO. Simultaneously with the closing of the IPO, we consummated the sale of
8,813,334 Private Placement Warrants to our Sponsor at a price of $1.50 per
warrant, generating gross proceeds of $13,220,000. Following the IPO and the
sale of the Private Placement Warrants, a total of $500,000,000 was placed in a
Trust Account and following the payment of certain transaction expenses.

On May 27, 2022, we borrowed $300,000 under the Working Capital Loans. If we
complete an initial Business Combination, we would repay the Working Capital
Loans. In the event that the initial Business Combination does not close, we may
use a portion of the proceeds held outside the Trust Account to repay such
loaned amounts but no proceeds from the Trust Account would be used to repay the
Working Capital Loans. Up to $1.5 million of the Working Capital Loans may be
convertible into warrants, at a price of $1.50 per warrant at the option of the
lender.

                                       19

--------------------------------------------------------------------------------

Table of Contents

In the three months ended September 30, 2022, we withdrew $447,621 of interest income from the Trust Account in order to satisfy tax obligations.



Uses of cash

                                              Nine Months Ended September 30,
                                                 2022                  2021               Change
Net cash used in operating activities       $    (1,370,399 )     $   (1,156,581 )    $     (213,818 )
Net cash provided by (used in) investing
activities                                  $       447,621       $ (500,000,000 )    $  500,447,621
Net cash provided by financing
activities                                  $       300,000       $  

502,391,740 $ (502,091,740 )




For the nine months ended September 30, 2022, cash used in operating activities
was $1,370,399. Net income of $16,902,177 was impacted by the non-cash changes
in fair value of the derivative liabilities of $15,797,600 and forward purchase
agreement of ($132,688), as well as the interest earned on cash held in trust
account of $3,011,653. Additionally, changes in operating assets and liabilities
provided $403,989 of cash used in operating activities.

For the nine months ended September 30, 2021, cash used in operating activities
was $1,156,581. Net income of $16,649,091 was impacted by the non-cash changes
in fair value of the derivative warrant liability and forward purchase agreement
of $18,374,401 and $462,191, respectively, the issuance costs attributed to the
warrant liabilities of $1,321,353, and $20,040 of interest income. Additionally,
changes in operating assets and liabilities provided $270,393 of cash used in
operating activities.

In order to fund working capital deficiencies and/or finance transaction costs
in connection with an initial Business Combination, our Sponsor or an affiliate
of our Sponsor or certain of our officers and directors may, but are not
obligated to, loan us funds as may be required. If we complete our initial
Business Combination, we would repay such loaned amounts. In the event that our
initial Business Combination does not close, we may use a portion of the working
capital held outside the Trust Account to repay such loaned amounts but no
proceeds from our Trust Account would be used for such repayment. Up to
$1,500,000 of such loans may be convertible into warrants, at a price of $1.50
per warrant at the option of the lender. The warrants would be identical to the
Private Placement Warrants, including as to exercise price, exercisability and
exercise period. As of September 30, 2022, we had $300,000 of such loans
outstanding.

As of September 30, 2022 and December 31, 2021, the Company had $352,615 and
$975,393 in cash not held in the Trust Account and available for working capital
purposes, respectively. The Company believes it will need to raise additional
funds in order to meet the expenditures required for operating the business. If
the Company's estimate of the costs of identifying a target business,
undertaking in-depth due diligence and negotiating an Initial Business
Combination are less than the actual amount necessary to do so, the Company may
have insufficient funds available to operate the business prior to the Initial
Business Combination. Moreover, the Company may need to obtain additional
financing either to complete the Initial Business Combination or to redeem a
significant number of our public shares upon completion of the Initial Business
Combination, in which case the Company may issue additional securities or incur
debt in connection with such Initial Business Combination. If the Company is
unable to complete the Business Combination because it does not have sufficient
funds available, the Company will be forced to cease operations and liquidate
the Trust Account.

In connection with the Company's assessment of going concern considerations in
accordance with Financial Accounting Standards Board's ("FASB") Accounting
Standards Codification ("ASC") Topic 205-40, Presentation of Financial
Statements-Going Concern, the Company has until February 23, 2023, to consummate
an initial business combination. It is uncertain that the Company will be able
to consummate an initial business combination by this time. If an initial
business combination is not consummated by this date, there will be a mandatory
liquidation and subsequent dissolution of the Company. Additionally, the Company
may not have sufficient liquidity to fund the working capital needs of the
Company through one year from the issuance of these financial statements.
Management has determined that the liquidity condition and mandatory
liquidation, should an initial business combination not occur, and potential
subsequent dissolution raises substantial doubt about the Company's ability to
continue as a going concern. No adjustments have been made to the carrying
amounts of assets or liabilities should the Company be required to liquidate
after February 2, 2023. The Company's sponsor, officers and directors may, but
are not obligated to, loan the Company funds from time to time or at any time,
in whatever amount they deem reasonable in their sole discretion, to meet the
Company's working capital needs.

Related Party Transactions

Please refer to Note 6, Related Party Transactions, in "Part 1. Financial Information - Item 1. Financial Statements" for a discussion of our related party transactions.


                                       20

--------------------------------------------------------------------------------

Table of Contents

Critical Accounting Policies and Estimates



Our management makes a number of significant estimates, assumptions and
judgments in the preparation of our financial statements. See "Note 2-Summary of
Significant Account Policies" in our 2021 Form 10-K, for a discussion of the
estimates and judgments necessary in our accounting for common stock subject to
possible redemption, and net income per common share. Any new accounting
policies or updates to existing accounting policies as a result of new
accounting pronouncements have been included in the notes to our condensed
financial statements contained in this Quarterly Report on Form 10-Q. The
application of our critical accounting policies may require management to make
judgments and estimates about the amounts reflected in the condensed financial
statements. Management uses historical experience and all available information
to make these estimates and judgments. Different amounts could be reported using
different assumptions and estimates.

Recent Accounting Pronouncements



Please refer to Note 2, Summary of Significant Accounting Policies, in "Part 1.
Financial Information - Item 1. Financial Statements" for a discussion of recent
accounting pronouncements and their anticipated effect on our business.

Effects of COVID-19 on Our Business



Management is continuing to evaluate the impact of the COVID-19 pandemic and has
concluded that while it is reasonably possible that the virus could have a
negative effect on the Company's financial position, results of its operations
and search for a target company, the specific impacts are not readily
determinable as of the date of these financial statements. The financial
statements do not include any adjustments that might result from the outcome of
this uncertainty.

JOBS Act

On April 5, 2012, the JOBS Act was signed into law. The JOBS Act contains
provisions that, among other things, relax certain reporting requirements for
qualifying public companies. We qualify as an "emerging growth company" under
the JOBS Act and are allowed to comply with new or revised accounting
pronouncements based on the effective date for private (not publicly traded)
companies. We elected to delay the adoption of new or revised accounting
standards, and as a result, we may not comply with new or revised accounting
standards on the relevant dates on which adoption of such standards is required
for non-emerging growth companies. As a result, our financial statements may not
be comparable to companies that comply with new or revised accounting
pronouncements as of public company effective dates.

As an "emerging growth company", we are not required to, among other things,
(i) provide an auditor's attestation report on our system of internal controls
over financial reporting pursuant to Section 404, (ii) provide all of the
compensation disclosure that may be required of non-emerging growth public
companies under the Dodd-Frank Wall Street Reform and Consumer Protection Act,
(iii) comply with any requirement that may be adopted by the PCAOB regarding
mandatory audit firm rotation or a supplement to the auditor's report providing
additional information about the audit and the financial statements (auditor
discussion and analysis), and (iv) disclose certain executive compensation
related items such as the correlation between executive compensation and
performance and comparisons of the CEO's compensation to median employee
compensation. These exemptions will apply for a period of five years following
the completion of our initial public offering or until we are no longer an
"emerging growth company," whichever is earlier.

© Edgar Online, source Glimpses